��������

Jenny Viklund is a Principal Scientist in Computational Chemistry at AstraZeneca, where they have been since 2022. With over 20 years of experience in pharmaceutical preclinical small molecule drug discovery, they previously served as Director of Protein Science and Drug Design at Sprint Bioscience from 2017 to 2021, leading various drug discovery projects. Jenny has contributed to multiple patent applications and publications throughout their career, showcasing their expertise in drug design and molecular modeling. They hold a Master of Science in Molecular Biotechnology from Uppsala University, earned in 2002.